Ketamine Maintenance: How Long Does Treatment Last? (Long-Term Guide 2026)

Most ketamine therapy guides cover induction — the first 6-12 sessions over 4-8 weeks that produce the initial response. Far less is written about what happens after that. How long do you keep doing this? How often? Does it stop working over time? When can you stop?

These questions matter because at-home ketamine therapy is a multi-year commitment for most patients, not a one-time treatment course. The induction phase gets the headlines; the maintenance phase is where most patients spend the majority of their treatment time.

Here's what long-term ketamine treatment actually looks like in 2026.

The two-phase structure of ketamine treatment

Phase 1: Induction (4-8 weeks)

The induction phase is the initial intensive treatment period that produces the first meaningful response. The standard protocol is 6-12 therapeutic-dose sessions over 4-8 weeks, typically twice-weekly during the first 2-3 weeks, then weekly through the rest.

For depression and anxiety, most patients notice some shift within 24-72 hours of the first session. Sustained response — meaningful baseline mood improvement — typically requires the full induction series. By the end of induction, the patient and physician have a clear picture of whether ketamine is producing clinically meaningful response, and at what dose.

About 60-75% of patients with treatment-resistant depression respond meaningfully to induction. The remaining 25-40% are non-responders or partial responders, and the maintenance discussion below is most relevant for the responder group.

Phase 2: Maintenance (months to years)

After induction, the goal shifts from acute symptom reduction to sustaining the gains. Most patients transition from weekly sessions to extended intervals — every 2-8 weeks depending on response durability.

The maintenance phase has no fixed endpoint. Some patients taper off entirely after 6-12 months. Others continue maintenance dosing indefinitely. The right answer depends on the underlying condition, the patient's response pattern, and what other treatments are running in parallel.

How often is "maintenance"? The real intervals

Maintenance dosing intervals vary widely based on response durability:

2-week interval (high-frequency maintenance)

Patients with the shortest response durability often need sessions every 2 weeks during the first 6-12 months of maintenance. This is more common in:

• Severe treatment-resistant depression with persistent residual symptoms
• PTSD with active trauma processing in concurrent therapy
• Bipolar depression (with mood stabilizer cover)
• Chronic pain with rapid symptom return between sessions

4-week interval (standard maintenance)

The most common maintenance schedule in stable responders. Monthly sessions tend to maintain the gains from induction without being so spaced out that symptoms return between sessions. This is the schedule most patients land on within 6-12 months of induction.

6-8 week interval (extended maintenance)

Patients with strong, durable response often extend to 6-8 week intervals. This is most common after 12+ months of stable treatment, in patients whose mood and functioning stay solid between sessions. Some patients continue at this interval for years.

As-needed maintenance

Some patients move to truly as-needed dosing — a session when life stressors, sleep disruption, or mood shifts indicate one. This is the lowest-frequency model and works for patients with strong baseline mental health between sessions, often paired with concurrent therapy or medication.

What happens to dose over time

Two questions come up repeatedly: does the dose need to increase over time, and does ketamine "stop working" with long-term use?

The dose generally stays stable

For most patients on stable maintenance schedules, the therapeutic dose established during induction stays roughly constant for months or years. Unlike some psychiatric medications where dose creeps upward over time to maintain effect, ketamine at therapeutic intermittent dosing tends to maintain its effect at a stable dose.

This is one of the practical advantages of session-based protocols over daily-dose protocols. The intermittent nature of treatment (every 2-8 weeks rather than daily) appears to avoid the tolerance development that would otherwise drive dose escalation.

Tolerance can develop with daily or near-daily use

Daily low-dose ketamine (the Joyous-style microdose model) is a different clinical question. The evidence base on long-term tolerance with daily dosing is genuinely thinner than for intermittent therapeutic dosing. Some patients on daily protocols report needing dose increases over months; others maintain stable response. This is an open area in 2026.

For the question "does intermittent therapeutic-dose ketamine produce tolerance," the answer in published clinical experience is: not meaningfully, at standard maintenance intervals.

Bladder concerns at very high cumulative exposures

Long-term, high-dose ketamine use (most documented in recreational users at much higher doses than therapeutic protocols use) can produce ketamine-induced cystitis — bladder inflammation and urinary symptoms. This is rare at therapeutic doses with monthly intervals, but worth monitoring with long-term use.

A reasonable ongoing monitoring schedule for patients in multi-year maintenance:

• Annual urinalysis to screen for early bladder changes
• Self-reporting of any new urinary symptoms (frequency, urgency, discomfort)
• Reduce frequency or discuss alternatives if bladder symptoms emerge

This is uncommon at therapeutic dosing but worth the periodic check given the long treatment timelines.

When to take a break

Some patients benefit from periodic treatment breaks. Common scenarios:

• Life-stage transition: pregnancy, surgery, major medication changes that warrant pausing ketamine
• Symptom remission: patients in stable remission for 6+ months may try a 3-6 month break to assess whether ongoing maintenance is still needed
• Tolerance management: in the rare case of subjective response decline, a 2-4 month break can sometimes restore responsiveness
• Cost or access changes: insurance changes, geographic moves, or financial constraints

A treatment break is a clinical conversation, not a unilateral decision. Stopping abruptly without a plan can produce symptom return that's avoidable with proper tapering. Discuss any planned break with your prescribing physician.

When to stop entirely

Some patients eventually taper off ketamine completely. The clinical signals that suggest readiness:

• 12+ months of stable response with extended maintenance intervals (every 6-8 weeks or longer)
• Concurrent treatment (therapy, exercise, sleep, social support) is well-established
• Underlying life stressors that drove the original symptoms have substantially resolved
• Patient and physician agree the therapeutic goals have been met

Stopping is typically gradual: extending intervals from 6-8 weeks to 3-6 months, then to as-needed. Some patients return to ketamine after years off; many don't.

For chronic conditions like treatment-resistant depression with strong family history, indefinite maintenance is often the right answer. For trauma-driven PTSD where the trauma processing has substantially resolved, treatment can sometimes end.

What 1-, 2-, and 5-year outcomes actually look like

Real-world ketamine maintenance outcomes data is still sparse compared to first-line antidepressants, but the published work shows:

At 1 year: Among patients who responded to induction, 60-75% maintain meaningful response with appropriate maintenance dosing. The dropout rate is typically 15-25% — patients who stop due to cost, life changes, or response decline.

At 2 years: Roughly 50-65% of induction responders are still on maintenance with stable response. Some have transitioned to extended intervals; some have tapered off; some have lost response and switched to other treatments.

At 5 years: The data thins out here. Among patients still in treatment at 2 years, most continue with stable response indefinitely. Tolerance development in the form of needing higher doses or shorter intervals is uncommon at therapeutic intermittent dosing. Bladder symptoms remain rare.

These numbers are better than the long-term outcomes for most TRD treatments. SSRIs lose effect over years in a substantial fraction of patients; ECT requires repeated courses; psychotherapy alone produces durable response in a smaller percentage. Ketamine maintenance, when it works at induction, tends to keep working.

Ketamine maintenance with concurrent treatment

Most patients on long-term ketamine maintenance are also doing other treatments:

Concurrent psychotherapy

The neuroplasticity window opened by each ketamine session is well-suited to concurrent therapy work. Patients in active CBT, EMDR, IFS, or psychodynamic therapy often see compounding benefit — the therapy produces faster gains during ketamine maintenance, and the maintenance preserves the therapy gains. This is the most common combination in well-functioning long-term outcomes.

Concurrent SSRIs/SNRIs

Most patients on ketamine maintenance continue their existing SSRI or SNRI. The two work through different mechanisms (serotonin vs. glutamate) and are generally complementary rather than redundant. Some patients eventually taper off the SSRI once ketamine maintenance is established; others continue both indefinitely.

Concurrent lifestyle interventions

Exercise, sleep optimization, and integration practices (meditation, journaling, somatic awareness) materially improve long-term ketamine outcomes. Patients who establish strong lifestyle foundations during induction tend to need less frequent maintenance.

For more on combined approaches, see medication safety with ketamine and ketamine and exercise.

Frequently Asked Questions

How long does ketamine therapy last?

The acute effect of a single ketamine session lasts 1-2 weeks for most patients with treatment-resistant depression — that's why maintenance dosing falls in the 2-8 week interval range. The cumulative benefit of a full induction series can last months without further dosing for some patients, though most need maintenance to sustain the gains. Long-term, patients on stable maintenance often continue treatment for 1-5+ years with sustained response.

How often do I need ketamine maintenance sessions?

Maintenance intervals depend on response durability, which varies significantly between patients. The standard schedule lands at every 4 weeks for most stable responders. Patients with severe TRD or active trauma processing often need 2-week intervals during the first year. Patients with strong, durable response may extend to 6-8 weeks or longer. The interval is adjusted based on how you actually feel between sessions.

Does ketamine stop working over time?

For most patients on intermittent therapeutic dosing (every 2-8 weeks), no. The dose required to produce response stays stable for months or years, and tolerance development is uncommon. Daily microdose protocols (like Joyous) raise different long-term questions about tolerance that haven't been fully answered in the published literature.

Can I stop ketamine therapy after the induction phase?

Some patients can — typically those with situational depression, anxiety, or trauma whose underlying drivers have substantially resolved. Most patients with chronic treatment-resistant depression need ongoing maintenance to sustain the gains. The decision to stop is a clinical conversation, ideally after 12+ months of stable response and gradual interval extension.

What's the cost of long-term ketamine maintenance?

At-home compounded ketamine maintenance typically runs $1,500-$3,000 per year for patients on monthly sessions ($250 clinical + $75-150 medication × 12 months). IV clinic maintenance runs $5,000-$15,000 per year. Spravato maintenance varies dramatically based on insurance coverage. The cost gap between modalities widens significantly over multi-year treatment.

Is long-term ketamine therapy safe?

At therapeutic intermittent dosing with proper medical oversight, yes. The most-watched concerns at long-term use are ketamine-induced cystitis (rare at therapeutic doses, more common at recreational doses) and tolerance development (uncommon at intermittent dosing). Annual urinalysis monitoring catches early bladder changes. Most patients on multi-year maintenance experience no significant safety issues.

When should I take a break from ketamine therapy?

Reasonable scenarios for a planned break: pregnancy, major surgery, significant medication changes, 6+ months of stable remission to assess whether ongoing maintenance is needed, or rare subjective response decline that might benefit from a 2-4 month reset. Discuss any planned break with your prescribing physician — abrupt stops without a plan can produce avoidable symptom return.

How does ketamine maintenance compare to staying on antidepressants?

The mechanisms are different — SSRIs work through serotonin reuptake inhibition with daily dosing; ketamine works through glutamate-mediated neuroplasticity with intermittent dosing. Many patients combine them. SSRI side effects (sexual dysfunction, weight changes, emotional flattening) often persist on chronic use; ketamine maintenance produces no equivalent daily-impairment burden. The cost profile is opposite — generic SSRIs are nearly free with insurance, while compounded ketamine is rarely covered. Both have their place, and many patients use both.

Can I switch ketamine programs during long-term maintenance?

Yes. Many patients change programs over a multi-year treatment course — often for cost, geographic relocation, or coverage changes. The clinical handoff requires a fresh intake at the new program but no formal medical reason prevents the switch. The medication dose typically stays stable across the transition; only the prescribing infrastructure changes.

The bottom line

Long-term ketamine therapy in 2026 is well-established as a multi-year treatment model for chronic conditions, not just a one-time intervention. The induction phase produces the initial response; the maintenance phase preserves it across years. Most patients land on monthly to bi-monthly maintenance dosing at a stable therapeutic dose, with concurrent psychotherapy and lifestyle interventions amplifying long-term outcomes.

The right maintenance schedule is determined by response durability — how you actually feel between sessions — not by a fixed protocol. Periodic clinical conversations adjust the interval based on real-time response patterns.

If you're in Florida or New Jersey and want to know whether at-home ketamine therapy fits your situation, the five-minute eligibility check is the start. For more on related topics: Best At-Home Ketamine Programs compares the major maintenance providers; Ketamine Therapy Cost breaks down long-term cost across pathways; Medication Safety with Ketamine covers compatible concurrent medications during multi-year maintenance.